| MeSH term | MeSH ID | Detail |
|---|---|---|
| Seizures | D012640 | 87 associated lipids |
| Nerve Degeneration | D009410 | 53 associated lipids |
| Peptic Ulcer | D010437 | 19 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Ischemic Attack, Transient | D002546 | 42 associated lipids |
| Substance-Related Disorders | D019966 | 2 associated lipids |
| Hepatitis | D006505 | 11 associated lipids |
| Hyperalgesia | D006930 | 42 associated lipids |
| Spinal Cord Injuries | D013119 | 34 associated lipids |
| Brain Damage, Chronic | D001925 | 6 associated lipids |
Anandamide
Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
Cross Reference
Introduction
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Anandamide?
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Anandamide
PubChem Associated disorders and diseases
What pathways are associated with Anandamide
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Anandamide?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Anandamide?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Anandamide?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Anandamide?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Anandamide?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Anandamide
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Mukherjee S et al. | Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors. | 2004 | Eur. J. Pharmacol. | pmid:15556131 |
| López-Miranda V et al. | Anandamide vehicles: a comparative study. | 2004 | Eur. J. Pharmacol. | pmid:15556148 |
| Rossato M et al. | Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. | 2005 | J. Clin. Endocrinol. Metab. | pmid:15562018 |
| Maccarrone M et al. | Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. | 2005 | Mol. Hum. Reprod. | pmid:15563449 |
| Patel S et al. | The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. | 2005 | J. Lipid Res. | pmid:15576840 |
| Fegley D et al. | Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. | 2005 | J. Pharmacol. Exp. Ther. | pmid:15579492 |
| Braun M and Kietzmann M | Ischaemia-reperfusion injury in the isolated haemoperfused bovine uterus: an in vitro model of acute inflammation. | 2004 | Altern Lab Anim | pmid:15601235 |
| Dinis P et al. | Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. | 2004 | J. Neurosci. | pmid:15601931 |
| Gavva NR et al. | AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. | 2005 | J. Pharmacol. Exp. Ther. | pmid:15615864 |
| Oz M et al. | Effects of saturated long-chain N-acylethanolamines on voltage-dependent Ca2+ fluxes in rabbit T-tubule membranes. | 2005 | Arch. Biochem. Biophys. | pmid:15639235 |
| Bari M et al. | Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. | 2005 | J. Biol. Chem. | pmid:15657045 |
| O'Sullivan SE et al. | Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta. | 2005 | Eur. J. Pharmacol. | pmid:15659311 |
| Kim SR et al. | Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro. | 2005 | J. Neurosci. | pmid:15659603 |
| Mbvundula EC et al. | Effects of cannabinoids on nitric oxide production by chondrocytes and proteoglycan degradation in cartilage. | 2005 | Biochem. Pharmacol. | pmid:15670582 |
| Kohro S et al. | Reductions in levels of bacterial superantigens/cannabinoids by plasma exchange in a patient with severe toxic shock syndrome. | 2004 | Anaesth Intensive Care | pmid:15675223 |
| Rodella LF et al. | AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation. | 2005 | Eur. J. Pharmacol. | pmid:15680264 |
| Oz M et al. | Additive effects of endogenous cannabinoid anandamide and ethanol on alpha7-nicotinic acetylcholine receptor-mediated responses in Xenopus Oocytes. | 2005 | J. Pharmacol. Exp. Ther. | pmid:15687372 |
| Lam PM et al. | Characterization and comparison of recombinant human and rat TRPV1 receptors: effects of exo- and endocannabinoids. | 2005 | Br J Anaesth | pmid:15722382 |
| Oddi S et al. | Confocal microscopy and biochemical analysis reveal spatial and functional separation between anandamide uptake and hydrolysis in human keratinocytes. | 2005 | Cell. Mol. Life Sci. | pmid:15723173 |
| Wiley JL et al. | Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice. | 2005 | Eur. J. Pharmacol. | pmid:15740725 |
| Mestre L et al. | Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis. | 2005 | J. Neurochem. | pmid:15748152 |
| Domenicali M et al. | Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. | 2005 | Gut | pmid:15753538 |
| Zhang N et al. | A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. | 2005 | Proc. Natl. Acad. Sci. U.S.A. | pmid:15764707 |
| Fezza F et al. | Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity. | 2005 | Anal. Biochem. | pmid:15766717 |
| Minowa S et al. | Capsaicin- and anandamide-induced gastric acid secretion via vanilloid receptor type 1 (TRPV1) in rat brain. | 2005 | Brain Res. | pmid:15781048 |
| Sandberg A and Fowler CJ | Measurement of saturable and non-saturable components of anandamide uptake into P19 embryonic carcinoma cells in the presence of fatty acid-free bovine serum albumin. | 2005 | Chem. Phys. Lipids | pmid:15784231 |
| De Bank PA et al. | A spectrophotometric assay for fatty acid amide hydrolase suitable for high-throughput screening. | 2005 | Biochem. Pharmacol. | pmid:15794939 |
| Fowler CJ and Tiger G | Cyclooxygenation of the arachidonoyl side chain of 1-arachidonoylglycerol and related compounds block their ability to prevent anandamide and 2-oleoylglycerol metabolism by rat brain in vitro. | 2005 | Biochem. Pharmacol. | pmid:15794945 |
| Chen P et al. | Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. | 2005 | Microvasc. Res. | pmid:15797258 |
| Kurabayashi M et al. | 2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver. | 2005 Jan-Feb | J Invest Surg | pmid:15804949 |
| Kvasnicka T | [Endocannabinoids--the new option in the treatment of metabolic syndrome and in smoking cessation]. | 2005 | Cas. Lek. Cesk. | pmid:15807291 |
| Tóth A et al. | Different vanilloid agonists cause different patterns of calcium response in CHO cells heterologously expressing rat TRPV1. | 2005 | Life Sci. | pmid:15820503 |
| Pacher P et al. | Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase. | 2005 | Am. J. Physiol. Heart Circ. Physiol. | pmid:15821037 |
| O'Sullivan SE et al. | The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide. | 2005 | Br. J. Pharmacol. | pmid:15821751 |
| Chen J et al. | Finding of endocannabinoids in human eye tissues: implications for glaucoma. | 2005 | Biochem. Biophys. Res. Commun. | pmid:15823551 |
| Chen JZ et al. | Preferred conformations of endogenous cannabinoid ligand anandamide. | 2005 | Life Sci. | pmid:15826873 |
| Randall MD | The cardiovascular actions of anandamide: more targets? | 2005 | Br. J. Pharmacol. | pmid:15834438 |
| Kwolek G et al. | Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats. | 2005 | Br. J. Pharmacol. | pmid:15834445 |
| Monteleone P et al. | Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. | 2005 | Neuropsychopharmacology | pmid:15841111 |
| Siegmund SV et al. | Anandamide induces necrosis in primary hepatic stellate cells. | 2005 | Hepatology | pmid:15841466 |
| Mishima K et al. | Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. | 2005 | Stroke | pmid:15845890 |
| Pisani A et al. | High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients. | 2005 | Ann. Neurol. | pmid:15852389 |
| Glass M et al. | Misidentification of prostamides as prostaglandins. | 2005 | J. Lipid Res. | pmid:15863842 |
| Osei-Hyiaman D et al. | Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. | 2005 | J. Clin. Invest. | pmid:15864349 |
| Ashton CH et al. | Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. | 2005 | J. Psychopharmacol. (Oxford) | pmid:15888515 |
| Guo Y et al. | N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. | 2005 | J. Biol. Chem. | pmid:15890658 |
| Kaplan BL et al. | Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide. | 2005 | Toxicol. Appl. Pharmacol. | pmid:15893538 |
| van der Stelt M et al. | A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. | 2005 | FASEB J. | pmid:15894565 |
| Vandevoorde S and Fowler CJ | Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate. | 2005 | Br. J. Pharmacol. | pmid:15895107 |
| Venderova K et al. | Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus. | 2005 | Exp. Neurol. | pmid:15899265 |